twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2016
vol. 118
 
Share:
Share:
abstract:
Review paper

Experimental studies on cell and gene therapies for retinal dystrophies with a particular focus on ABCA4 retinopathies

Aneta Ścieżyńska
1
,
Dominika Oziębło
2
,
Monika Ołdak
1, 2, 3

1.
Katedra i Zakład Histologii i Embriologii, Centrum Biostruktury, Warszawski Uniwersytet Medyczny
2.
Zakład Genetyki, Instytut Fizjologii i Patologii Słuchu w Warszawie
3.
Samodzielny Publiczny Kliniczny Szpital Okulistyczny w Warszawie
Online publish date: 2017/11/29
View full text Get citation
 
PlumX metrics:
Retinal dystrophies lead to gradual irreversible vision deterioration. The ABCA4 retinopathies constitute an important group of retinal dystrophies. However, there are no effective therapies available for this group of diseases. Yet, with the advent of molecular therapies, the development of prospective therapeutic approaches seems feasible. The paper summarizes recent advances in gene and cell therapy that may be implemented in retinal dystrophies, especially in ABCA4-associated diseases.
keywords:

ABCA4 gene, Stargardt disease, retinal dystrophies, gene therapy, cell therapy, clinical trials

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.